Doble A , Martin I , Nutt D (2003) Calming the brain. Martin Dunitz, London
2.
Evans S M , Funderburk F R , Griffiths R R (1990) Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability . J Pharmacol Exp Ther255: 1246-1255
3.
Hajak G , Muller W E , Wittchen H U , Pittrow D , Kirch W (2003) Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data .Addiction98: 1371-1378
4.
Jaffe J H , Bloor R , Crome I , Carr M , Alam F , Simmons A , Meyer R E (2004) A postmarketing study of relative abuse liability of hypnotic sedative drugs . Addiction99: 165-173
5.
Malizia A L , Gunn R N , Wilson S J , Waters S H , Bloomfield P M , Cunningham V J , Nutt D J (1996) Benzodiazepine site pharmacokinetic/pharmacodynamics quantification in man: direct measurement of drug occupancy and effects on the human brain in vivo . Neuropharmacology35: 1483-1491
6.
Rudolph U , Mohler H (2004) Analysis of GABA-A receptor function and dissection of the pharmacology of benzodiazepines and general anaesthetic through mouse genetics . Ann Rev Pharmacol Toxicol44: 475-498
